CRBP Hedge Fund Ownership (Q2 2026)

Corbus Pharmaceuticals Hldgs (CRBP)

107 + Investors. Track Smart Money conviction in CRBP. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — CRBP

Based on 106 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added CRBP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (96% of max)

96% of all-time peak

106 hedge funds hold CRBP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +26% more funds vs a year ago

fund count last 6Q

+22 new funds entered over the past year (+26% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 4 quarters from the low — a sharp move.

🟡

Slight buying edge — 58% buying

57 buying41 selling

Last quarter: 57 funds bought or added vs 41 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

➡️

Steady new buyers — ~23 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 13 → 21 → 27 → 23. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

📌

Mixed — 37% long-term, 29% new

■ 37% conviction (2yr+) ■ 34% medium ■ 29% new

Of the 106 current holders: 39 (37%) held >2 years, 36 held 1–2 years, and 31 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

📈

Growing discovery — still being found

15 → 13 → 21 → 27 → 23 new funds/Q

New funds entering each quarter: 13 → 21 → 27 → 23. A growing number of institutions are discovering CRBP each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🏛️

Veteran-anchored — 51% veterans vs 29% newcomers

■ 51% veterans ■ 20% 1-2yr ■ 29% new

Entry-cohort mix of 114 holders: 58 (51%) are 2+ year veterans, 23 entered 1–2 years ago, and 33 (29%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

📋

Smaller funds dominant — 15% AUM from top-100

15% from top-100 AUM funds

25 of 106 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.0

out of 10

Moderate Exit Risk

Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	107	106	0.94%
13F Shares	15M	13M	17.36%
Total Value	$145M	$123M	17.91%
New Positions	27	23	+4
Increased Positions	31	33	-2
Closed Positions	26	16	+10
Reduced Positions	22	22	-
Total Calls	7	6	16.67%
Total Puts	3	2	50.0%
PUT/CALL Ratio	0.43	0.33	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

107

106

0.94%

13F Shares

15M

13M

17.36%

Total Value

$145M

$123M

17.91%

New Positions

Increased Positions

-2

Closed Positions

+10

Reduced Positions

Total Calls

16.67%

Total Puts

50.0%

PUT/CALL Ratio

0.43

0.33

Bullish

Institutional Holders (2026 Q2)

107 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CRBP. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 CRBP holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Stonepine Capital Management, LLC	1.87%	425,000	$4.0M
2	Jones Hill Capital LP	1.30%	653,572	$6.1M
3	Cormorant Asset Management, LP	1.13%	2,344,971	$22.0M
4	Exome Asset Management LLC	1.07%	184,914	$1.7M
5	Prosight Management, LP	1.05%	650,000	$6.1M
6	Diadema Partners LP	0.75%	633,800	$5.9M
7	Verdad Advisers, LP	0.57%	63,603	$597K
8	Rangeley Capital, LLC	0.38%	44,000	$413K
9	Diadema Partners LP	0.36%	301,264	$2.8M
10	Orbimed Advisors LLC	0.30%	1,737,287	$16.3M
11	Persistent Asset Partners Ltd	0.22%	76,919	$722K
12	DAFNA Capital Management LLC	0.19%	107,773	$1.0M
13	ADAR1 Capital Management, LLC	0.18%	421,787	$4.0M
14	Velan Capital Investment Management LP	0.15%	26,000	$244K
15	Sectoral Asset Management Inc	0.13%	20,000	$188K
16	Seven Fleet Capital Management LP	0.03%	21,432	$201K
17	Aster Capital Management (DIFC) Ltd	0.03%	16,509	$114K
18	ADAR1 Capital Management, LLC	0.03%	60,000	$563K
19	Caption Management, LLC	0.03%	572,300	$5.4M
20	Aberdeen Group plc	0.02%	1,321,750	$12.4M
21	Pale Fire Capital SE	0.02%	24,301	$228K
22	Susquehanna Portfolio Strategies, LLC	0.01%	75,979	$713K
23	Advisory Services Network, LLC	0.01%	89,951	$844K
24	XTX Topco Ltd	0.01%	67,654	$635K
25	Y-Intercept (Hong Kong) Ltd	0.00%	22,646	$212K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Corbus Pharmaceuticals Hldgs (CRBP)

What does the Smart Money Trend signal show for CRBP?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added CRBP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CRBP?

Slight buying edge — 58% buying: Last quarter: 57 funds bought or added vs 41 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CRBP holders?

Smaller funds dominant — 15% AUM from top-100: 25 of 106 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held CRBP?

Mixed — 37% long-term, 29% new: Of the 106 current holders: 39 (37%) held >2 years, 36 held 1–2 years, and 31 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Corbus Pharmaceuticals Hldgs (CRBP)

Smart Money Signals — CRBP

Buying streak — 3 quarters in a row

At the ownership peak (96% of max)

Fast accumulation — +26% more funds vs a year ago

Slight buying edge — 58% buying

Steady new buyers — ~23 new funds per quarter

Mixed — 37% long-term, 29% new

Growing discovery — still being found

Veteran-anchored — 51% veterans vs 29% newcomers

Smaller funds dominant — 15% AUM from top-100

Institutional Sentiment Summary — CRBP

Hedge Fund Ownership: CRBP

Market Analysis: CRBP

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: CRBP

Hedge Fund Positioning: CRBP

Statistics: CRBP

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Corbus Pharmaceuticals Hldgs (CRBP)

Welcome to 13Foresight!